Mineralys Therapeutics launches $175M public offering

1 week ago 1

Mineralys Therapeutics (NASDAQ:MLYS) has commenced a $175M underwritten public offering of common stock.
A 30-day option allows underwriters to purchase up to an additional $26.25M in shares.
All shares in the offering will be sold by the company.
Proceeds will